DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
4.395
+0.145 (3.41%)
At close: Feb 21, 2025, 4:00 PM
4.400
+0.005 (0.11%)
After-hours: Feb 21, 2025, 4:08 PM EST
DBV Technologies Market Cap
DBV Technologies has a market cap or net worth of $85.42 million as of February 21, 2025. Its market cap has decreased by -50.31% in one year.
Market Cap
85.42M
Enterprise Value
48.85M
1-Year Change
-50.31%
Ranking
Category
Stock Price
$4.40
Market Cap Chart
Since October 22, 2014, DBV Technologies's market cap has decreased from $844.80M to $85.42M, a decrease of -89.89%. That is a compound annual growth rate of -19.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 84.80M | 42.28% |
| Dec 31, 2024 | 59.60M | -67.52% |
| Dec 29, 2023 | 183.50M | -36.22% |
| Dec 30, 2022 | 287.70M | 63.47% |
| Dec 31, 2021 | 176.00M | -28.57% |
| Dec 31, 2020 | 246.40M | -68.16% |
| Dec 31, 2019 | 773.80M | 141.13% |
| Dec 31, 2018 | 320.90M | -73.54% |
| Dec 29, 2017 | 1.21B | -28.69% |
| Dec 30, 2016 | 1.70B | 22.23% |
| Dec 31, 2015 | 1.39B | 39.07% |
| Dec 31, 2014 | 1.00B | 18.43% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |